| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |